Literature DB >> 8840554

Mutations in SOX9 cause both autosomal sex reversal and campomelic dysplasia.

J W Foster1.   

Abstract

The human testis determining factor (SRY) has been cloned from the Y chromosome. This gene is a dominant inducer of male differentiation. Mutations in the SRY gene result in an XY individual developing as a sex reversed phenotypic female. Sex reversal in humans can also be caused by mutations located in autosomal or X-linked loci. One such sex-reversing locus (SRAI) is associated with the developmental disorder campomelic dysplasia (CD). Both these syndromes were mapped to human chromosome 17q by the identification of balanced reciprocal translocations in five unrelated patients. The translocation breakpoint of one such XY-female CD patient was mapped and the region surrounding it cloned. The closest distal marker used to map the translocation breakpoint was the SOX9 gene. Because of the close proximity of this gene to the breakpoint, it was subjected to mutation analysis in patients without overt chromosome rearrangements. Analysis of DNA from these patients and their parents identified de novo mutations in the SOX9 gene in patients with both autosomal sex reversal and CD. This showed that mutations in the SOX9 gene are responsible for both syndromes.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8840554     DOI: 10.1111/j.1442-200x.1996.tb03515.x

Source DB:  PubMed          Journal:  Acta Paediatr Jpn        ISSN: 0374-5600


  12 in total

Review 1.  Amelia: a multi-center descriptive epidemiologic study in a large dataset from the International Clearinghouse for Birth Defects Surveillance and Research, and overview of the literature.

Authors:  Eva Bermejo-Sánchez; Lourdes Cuevas; Emmanuelle Amar; Marian K Bakker; Sebastiano Bianca; Fabrizio Bianchi; Mark A Canfield; Eduardo E Castilla; Maurizio Clementi; Guido Cocchi; Marcia L Feldkamp; Danielle Landau; Emanuele Leoncini; Zhu Li; R Brian Lowry; Pierpaolo Mastroiacovo; Osvaldo M Mutchinick; Anke Rissmann; Annukka Ritvanen; Gioacchino Scarano; Csaba Siffel; Elena Szabova; María-Luisa Martínez-Frías
Journal:  Am J Med Genet C Semin Med Genet       Date:  2011-10-14       Impact factor: 3.908

Review 2.  SRY and the standoff in sex determination.

Authors:  Leo DiNapoli; Blanche Capel
Journal:  Mol Endocrinol       Date:  2007-07-31

3.  Related function of mouse SOX3, SOX9, and SRY HMG domains assayed by male sex determination.

Authors:  D E Bergstrom; M Young; K H Albrecht; E M Eicher
Journal:  Genesis       Date:  2000 Nov-Dec       Impact factor: 2.487

4.  AP-1 family members act with Sox9 to promote chondrocyte hypertrophy.

Authors:  Xinjun He; Shinsuke Ohba; Hironori Hojo; Andrew P McMahon
Journal:  Development       Date:  2016-07-28       Impact factor: 6.868

5.  Rare diseases in clinical endocrinology: a taxonomic classification system.

Authors:  G Marcucci; L Cianferotti; P Beck-Peccoz; M Capezzone; F Cetani; A Colao; M V Davì; E degli Uberti; S Del Prato; R Elisei; A Faggiano; D Ferone; C Foresta; L Fugazzola; E Ghigo; G Giacchetti; F Giorgino; A Lenzi; P Malandrino; M Mannelli; C Marcocci; L Masi; F Pacini; G Opocher; A Radicioni; M Tonacchera; R Vigneri; M C Zatelli; M L Brandi
Journal:  J Endocrinol Invest       Date:  2014-11-07       Impact factor: 4.256

6.  NF-kappaB mediates inhibition of mesenchymal cell differentiation through a posttranscriptional gene silencing mechanism.

Authors:  Raquel Sitcheran; Patricia C Cogswell; Albert S Baldwin
Journal:  Genes Dev       Date:  2003-10-01       Impact factor: 11.361

7.  Genetic regulation of embryological limb development with relation to congenital limb deformity in humans.

Authors:  Guy Barham; Nicholas M P Clarke
Journal:  J Child Orthop       Date:  2008-02-07       Impact factor: 1.548

8.  A Col9a1 enhancer element activated by two interdependent SOX9 dimers.

Authors:  Mary Ann Genzer; Laura C Bridgewater
Journal:  Nucleic Acids Res       Date:  2007-01-30       Impact factor: 16.971

Review 9.  CEACAM1: Expression and Role in Melanocyte Transformation.

Authors:  Gabriela Turcu; Roxana Ioana Nedelcu; Daniela Adriana Ion; Alice Brînzea; Mirela Daniela Cioplea; Lucia Beatrice Jilaveanu; Sabina Andrada Zurac
Journal:  Dis Markers       Date:  2016-08-24       Impact factor: 3.434

10.  SOX9 indirectly regulates CEACAM1 expression and immune resistance in melanoma cells.

Authors:  Shira Ashkenazi; Rona Ortenberg; Michal Besser; Jacob Schachter; Gal Markel
Journal:  Oncotarget       Date:  2016-05-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.